Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences: Peter Fromen

Pacific Biosciences Chief Commercial Officer Peter Fromen has notified the company of his intention to resign, effective May 20, to pursue new opportunities.

His decision to resign "did not result from any disagreement with the company on any matter relating to the company's operations, policies or practices," PacBio said in a From 8-K filed May 17 with the US Securities and Exchange Commission.

CEO Christian Henry will take over marketing responsibilities until a successor is appointed and Chris Seipert, VP of customer experience, will take over sales, service, and support responsibilities.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.